Training on injection techniques can build confidence and reduce anxiety
Tirzepatide is the first in a class of drugs called dual GLP-1/GIP receptor agonists that activate the receptor for another gut hormone, glucose-dependent insulinotropic polypeptide (GIP), in addition to the GLP-1 receptor
The risk may be higher when appetite is very low, protein intake drops, and resistance training is absent
Ozempic, Wegovy, Mounjaro and Other GLP-1 Agonists Side Effects Canadian Class Action ON Sep 29, 2023 [en] Complaint (Louisiana) ON Sep 19, 2023 [en] Complaint (Pennsylvania) QC Aug 02, 2023 [en] Complaint (Louisiana) CONSUMER LAW GROUP is investigating a Canada-wide class action lawsuit against Novo Nordisk Canada Inc
Your guided journey begins here
Previous patients are often very willing to share their experiences and add perspective